<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE ichicsr>
<ichicsr lang="en">
<ichicsrmessageheader>
<messagetype>ichicsr</messagetype>
<messageformatversion>2.1</messageformatversion>
<messageformatrelease>1.0</messageformatrelease>
<messagenumb>d0d7003b-9ffc-11ee-9a01-28dfeb6bed73-BIO</messagenumb>
<messagesenderidentifier>simplesafety</messagesenderidentifier>
<messagereceiveridentifier>ss</messagereceiveridentifier>
<messagedateformat>204</messagedateformat>
<messagedate>202306271817</messagedate>
</ichicsrmessageheader>
<safetyreport>
<safetyreportversion>0</safetyreportversion>



<transmissiondateformat>102</transmissiondateformat>
<transmissiondate>20230627</transmissiondate>
<reporttype>1</reporttype>
<serious>2</serious>










<authoritynumb>3714031863058202300023</authoritynumb>




<sender>

<senderorganization>simplesafety</senderorganization>
</sender>
<receiver>

<receiverorganization>ss</receiverorganization>
</receiver>
<patient>
<patientinitial>unknown</patientinitial>




<patientbirthdateformat>102</patientbirthdateformat>
<patientbirthdate>19870624</patientbirthdate>
<patientonsetage>36</patientonsetage>
<patientonsetageunit>801</patientonsetageunit>


<patientagegroup>5</patientagegroup>
<patientweight>60.0</patientweight>

<patientsex>2</patientsex>




<patientdeath>
<patientdeathdateformat>102</patientdeathdateformat>


</patientdeath><patientdeathcause>

<patientdeathreport>0</patientdeathreport>
</patientdeathcause><medicalhistoryepisode>

<patientepisodename>10010741</patientepisodename>






</medicalhistoryepisode><reaction>
<primarysourcereaction>Blurred vision</primarysourcereaction>

<reactionmeddrallt>10005886</reactionmeddrallt>



<reactionstartdateformat>102</reactionstartdateformat>
<reactionstartdate>20230624</reactionstartdate>






<reactionoutcome>2</reactionoutcome>
</reaction><drug>
<drugcharacterization>1</drugcharacterization>
<medicinalproduct>Levofloxacin Hydrochloride Eye Drops</medicinalproduct>






<drugstructuredosageunit>012</drugstructuredosageunit>






<drugdosageform>Eye Drops Solution</drugdosageform>
<drugadministrationroute>047</drugadministrationroute>


<drugstartdateformat>102</drugstartdateformat>
<drugstartdate>20230624</drugstartdate>
<drugenddateformat>102</drugenddateformat>
<drugenddate>20230624</drugenddate>


<actiondrug>0</actiondrug>


<activesubstance>
<activesubstancename>Levofloxacin Hydrochloride Eye Drops</activesubstancename>
</activesubstance>
<drugreactionrelatedness>


<drugassessmentsource>Reporter</drugassessmentsource>
<drugassessmentmethod>Global Introspection</drugassessmentmethod>
<drugresult>probably</drugresult>
</drugreactionrelatedness><drugreactionrelatedness>


<drugassessmentsource>Company</drugassessmentsource>
<drugassessmentmethod>Global Introspection</drugassessmentmethod>
<drugresult>probably</drugresult>
</drugreactionrelatedness></drug><summary>
<narrativeincludeclinical>The patient visited the hospital on June 24, 2023 due to redness and swelling of the eyes. She was diagnosed with conjunctivitis and was prescribed to use levofloxacin hydrochloride eye drops, 0.04 ml/time, four times a day to eliminate the inflammation. The patient went home and used levofloxacin hydrochloride eye drops as prescribed, starting at 11:00 p.m. on June 24. After using the drops, the patient felt blurred vision at around 12:00 p.m. She contacted the doctor by phone and was instructed to come to the hospital at 14:00 p.m. for examination. After arriving at the hospital, the doctor examined the patient and found no abnormalities. The doctor suspected that the allergic reaction was caused by the patient's use of levofloxacin hydrochloride eye drops, so the doctor ordered to stop using it and replace it with other antibiotic eye drops and continued observation. At 15:00 the patient reported that the symptoms of blurred vision improved and no further levofloxacin hydrochloride eye drops were used subsequently.</narrativeincludeclinical>
</summary></patient></safetyreport>
</ichicsr>